|Mr. Daniel L. Reuvers||Pres, CEO & Director||836.22k||N/A||1963|
|Mr. Brent A. Moen||Chief Financial Officer||528.35k||N/A||1967|
|Mr. Mark W. Aldridge||VP of Operations||N/A||N/A||N/A|
|Mr. Peter C. Schaubach||Chief Information Officer||N/A||N/A||N/A|
|Ms. Sunday J. Hoy||VP & Compliance Officer||N/A||N/A||N/A|
|Mr. Eric Pauls||Sr. VP of Sales||N/A||N/A||N/A|
|Ms. Juleen F. Krings||Chief HR Officer||N/A||N/A||N/A|
|Mr. Thomas F. O'Donnell Jr.||Chief Medical Officer||N/A||N/A||N/A|
|Mr. Darren J. Wennen||Sr. VP of Commercial Operations||N/A||N/A||N/A|
|Ms. Kristie Burns||Sr. VP of Marketing & Clinical Affairs||N/A||N/A||N/A|
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Tactile Systems Technology, Inc.’s ISS governance QualityScore as of 26 September 2021 is 5. The pillar scores are Audit: 4; Board: 3; Shareholder rights: 5; Compensation: 7.